Department of Psychiatry and Behavioral Sciences

Selected Research Faculty

Jonathan E. Alpert MD, PhD

Novel treatments for mood disorders; depressive subtypes; research ethics and design; medical education


Julia Arnstein MD

Behavioral medicine including adherence to medication-taking, nicotine dependence, and substance abuse; addiction with comorbid chronic medical illness


Anita Autry PhD

Understanding neural circuits that control social behavior and how these circuits are regulated under physiological and pathological conditions


Pablo Castillo MD, PhD

Excitatory and inhibitory synaptic transmission and plasticity under physiological and brain disease conditions such as Alzheimer’s disease, epilepsy, autism, schizophrenia and drug abuse


Mirnova E. Ceide MDMirnova E. Ceide MD

Understanding cognitive and motor function in older adults; dementia; geriatric psychiatry


Henry Chung MD

Behavioral health integration


Chinazo Cunningham MD, MS

Access to care and health outcomes among drug users with or at-risk for HIV; buprenorphine treatment in primary care settings; opioid use, misuse, and addiction; collaborating with community-based organizations


Emad N. Eskandar, MDEmad N. Eskandar MD

Developing novel neurosurgical and neuromodulatory approaches for neuropsychiatric conditions


Noboru Hiroi PhD

Genetic bases of nicotine dependence, 22q11 syndrome, and other neuropsychiatric conditions


Eric Hollander MD

Novel treatments including CBDV in Autism Spectrum Disorder (ASD); oxytocin in Prader Willi Syndrome (PWS); vasopressin 1a antagonists in ASD; alpha-1 chemotrypsin in ASD; Intermittent Explosive Disorder; Tourette Syndrome; transcranial magnetic stimulation (TMS) in OCD and ASD


Bryen A. Jordan PhD

Synaptic plasticity; RNA transport and local translation in neurons; synapse-to-nucleus signaling; proteomic analysis of the dynamics of synaptic junctions; molecular mechanisms underlying neuropsychiatric disorders.


Kamran Khodakhah PhD

Cerebellar physiology and function; cerebellar contributions to motor coordination and movement disorders as well as to other disorders including Autism, schizophrenia, addiction and migraine.


Herbert M. Lachman MD

Induced pluripotent stem cell technology to study the molecular basis of schizophrenia and autism by RNA-seq and ChIP-seq; patient-specific lines and isogenic knockout lines, generated by CRISP-Cas9.


Richard Lipton MD

Longitudinal population studies that link stress, pain and cognitive performance to genetics, biomarkers and neuroimaging


Michael L. Lipton MD, PhD

Neuroimaging; Traumatic Brain Injury (TBI); concussion injury; image processing and analysis, diffusion imaging; white matter microstructure; cognitive dysfunction


Alain Litwin MD

Models of hepatitis C virus (HCV) care for drug users; access to effective care for HCV-infected patients.


Mark Mehler MD

Stem Cell Biology and Regenerative Medicine; Epigenetics and Evolutionary Biology; Developmental Pathogenesis of Neurodegenerative Diseases; Cytokine Biology/Signal Transduction Pathways in Neurodevelopmental Disorders (Autism/ASD)


Sophie Molholm PhD

Neurobiology of development disorders, particularly autism, with focus on how the human brain processes and integrates sensory inputs to impact perception and behavior, and the role of attention.


Wenzhu Mowrey PhDWenzhu Mowrey PhD

Biostatistical approaches and study design in neuropsychiatric and neuroimaging research


Anne Murphy PhD

Parent-child treatment for parents with a history of abuse or neglect; creating positive social emotional and developmental outcomes for offspring of parents with trauma histories.


Shadi Nahvi MD MS

Interventions to treat tobacco use among opiate dependent patients in methadone maintenance treatment, and among other vulnerable populations


Saleem M. Nicola PhD

Electrophysiological, behavioral and pharmacological approaches to studying neural circuits underlying reward-seeking and addictive behaviors.


Patricia (Tia) Powell MD

Bioethics issues in public policy, dementia, mediation/consultation, end of life care, bioethics education and public health disasters.


Lucas Sjulson, MD, PhDLucas Sjulson MD, PhD

Understanding dysregulation of frontolimbic circuits in drug addiction-related behaviors; Developing and validating new technologies and targets for gene-based clinical neuromodulation.


Monday, April 30, 2018 | 12:00 PM
"Designing the Next Generation of Vaccines for Cytomegalovirus"
Price Center/Block Pavilion, LeFrak Auditorium

view calendar


Media Spotlight

ABC News quotes Einstein and Montefiore psychiatrist Dr. Karinn Glover and resident Dr. Italo Brown on why the Black Panther movie offers a possible boost to the mental health of many in the African-American community. (Thursday, Mar 01, 2018)

media coverage on other stories

Click here to log in